Evotec SE SEC filings EVOTF

Evotec SE has 190 filings in SEC EDGAR's recent list, going back to Sep 19, 2007. Its latest annual report, Form 20-F, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 14, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 1, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 6, 2026 —
SCHEDULE 13D Ownership over 5% (active) Mar 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 16, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 29, 2025 —
SC 13D Ownership over 5% (active) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2023 —
SC 13G Ownership over 5% (passive) Feb 2, 2022 —
SC 13D Ownership over 5% (active) Nov 16, 2021 —
SC 13G/A Amended ownership over 5% (passive) Oct 2, 2009 —
SC 13G Ownership over 5% (passive) May 15, 2008 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
EVO (Nasdaq), EVOTF (OTC)
Fiscal year ends
December 31
Incorporated in
Germany
Headquarters
Hamburg
SEC filer status
Large accelerated filer
SEC CIK
1412558
Former names
Evotec AG (until Sep 23, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.